SCI assists Ministries of Health across sub-Saharan Africa to control and eliminate schistosomiasis and soil transmitted helminths (STH: whipworm, hookworm, roundworm) from their population utilising the World Health Organization’s Drug Donation Programme for praziquantel and albendazole. 230 million people, one-third of the total population of Africa, need a regular annual treatment of praziquantel, and 400 million people need a regular annual treatment of albendazole, to eliminate these parasitic diseases from their bodies.
SCI treats children and at-risk adults for schistosomiasis and STH, preventing anaemia, impaired growth and development in children and the development of life-threatening conditions of bladder cancer, kidney malfunction or liver and spleen damage.
Located within Imperial College London, SCI combines implementation with world-class research to ensure their treatment programmes achieve maximum effectiveness.
When you buy any type of insurance from GGIS, with every policy we will fund one year’s lifesaving treatment to 2 young children in Africa through our chosen charity, SCI.